Metraipolis › archive › dc_af57909a552a

Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent — Europe PMC PMID:41291275

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41291275
DOI
10.1007/s00210-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-08T05:55:02.758Z
SHA-256 of the archived text
39809e70e9bff1580a0fc03523c23418a18c995904071339b8e7611921ca2d1f
Stable URL of this page
https://metraipolis.com/documento/dc_af57909a552a

How to cite

Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent — Europe PMC PMID:41291275 — Europe PMC (en), https://europepmc.org/article/MED/41291275 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af57909a552a (Metraipolis archive dc_af57909a552a, sha256 39809e70e9bff1580a0fc03523c23418a18c995904071339b8e7611921ca2d1f)
BibTeX
@misc{dcaf57909a552a,
  title = {Bioequivalence assessment of imeglimin hydrochloride tablet, a novel glimin-class antidiabetic agent — Europe PMC PMID:41291275},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41291275},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af57909a552a; sha256 39809e70e9bff1580a0fc03523c23418a18c995904071339b8e7611921ca2d1f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291275. Agents can read the archived copy with the MCP tool read_document.